Antidepressant Therapies Is Fastest Growing Segment Fueling The Growth Of Serotonin Norepinephrine Inhibitor Market

Serotonin Norepinephrine Inhibitor Market 


The Global Serotonin Norepinephrine Inhibitor Market is estimated to be valued at US$ 6.53 Bn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Serotonin-norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant medications that help treat major depressive disorder, generalized anxiety disorder, fibromyalgia and neuropathic pain by increasing levels of serotonin and norepinephrine in the brain. SNRIs have advantages over SSRIs as they act on both serotonin and norepinephrine rather than just serotonin alone.

Market key trends:
One of the emerging trends in the serotonin norepinephrine inhibitors market is the increased R&D activities for developing new treatment therapies combining multiple drug product types. Numerous clinical trials are currently underway to study the therapeutic efficacy of combining SNRIs with other anticonvulsants, antipsychotics or mood stabilizers for treating various mental health conditions including depression. Finding new drug combinations can help address treatment-resistant depression and provide alternative treatment options that work better with fewer side effects.

Segment Analysis
The global serotonin norepinephrine inhibitor market is dominated by the major depression segment. Major depression accounts for over 75% share of the overall serotonin norepinephrine inhibitor market. This is because serotonin norepinephrine inhibitors are primarily used for the treatment of major depressive disorder. Serotonin norepinephrine inhibitors have proven to be effective in alleviating symptoms associated with major depression such as feelings of worthlessness, guilt, inability to concentrate, and sadness.

Key Takeaways

The Global Serotonin Norepinephrine Inhibitor Market is expected to witness high growth, exhibiting a CAGR of 3.8% over the forecast period, due to increasing prevalence of depression globally. According to WHO, over 264 million people suffer from depression worldwide.

Regional analysis - North America dominates the global serotonin norepinephrine inhibitor market due to high awareness regarding mental health disorders and availability of advanced healthcare facilities in the region. However, Asia Pacific is expected to grow at the fastest pace during the forecast period owing to the presence of vast population base suffering from depression in countries such as China and India.

Key players - Key players operating in the serotonin norepinephrine inhibitor market are Pfizer Inc., Eli Lilly and Company, Allergan Plc., AstraZeneca Plc., Forest Laboratories Inc., Johnson & Johnson, Lundbeck A/S, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wyeth Pharmaceuticals Inc., Zydus Cadila Healthcare Ltd. Pfizer Inc. dominates the global market owing to its diversified product offering in antidepressants.

Read More - https://www.dailyprbulletin.com/serotonin-norepinephrine-inhibitor-market-projected-to-boost-the-growth-of-serotonin-norepinephrine-inhibitor-market/

Comments

Post a Comment

Popular posts from this blog

Optical Transport Network Market Is Estimated To Witness High Growth Owing To Opportunity In Deployment Of 400G Systems

Image
Optical Transport Network Market  Optical transport network (OTN) refers to the transport of data, voice and video traffic over long distances using optical technologies. OTN solutions facilitate transmission bandwidth rates ranging from 10Gbit/s to over 100Gbit/s over existing fiber infrastructure. They deploy advanced multiplexing techniques such as dense wave division multiplexing (DWDM) and time-division multiplexing (TDM) that boost transmission and switching capabilities. OTN solutions deliver reduced latency and enhanced reliability for meeting rising bandwidth demands. The global Optical Transport Network Market is estimated to be valued at US$ 22.32 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising deployment of 400G networks across internet data centers and telecom backbones is estimated to present lucrative growth opportuniti...
Read more

Ostomy Care Accessories Market Is Estimated To Witness High Growth Owing To Opportunity In Improving Patient Lifestyles

Image
Ostomy Care Accessories Market Ostomy accessories are medical devices used along with an ostomy appliance or pouching system to help improve the quality of life of people who have had ostomy surgery. Some common ostomy accessories include belt or pants/undergarment clips, skin barriers, moisture-collecting bags, adhesive removers, and protecting sheets. The growing number of patients suffering from inflammatory bowel disease, colorectal cancer, and other gastrointestinal disorders have resulted in increasing demand for ostomy care accessories. These accessories play a crucial role in providing security, discretion, and comfort to ostomates while performing regular activities. The global Ostomy Care Accessories Market is estimated to be valued at US$ 3.69 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Improving patient lifestyles is one of the major...
Read more

Schmallenberg Virus Treatment Is Estimated To Witness High Growth Owing To Opportunity Of Development Of New Drugs And Vaccines

Image
Schmallenberg Virus Treatment Market Schmallenberg virus (SBV) is an orthobunyavirus that affects domestic and wild ruminants such as cattle, sheep and goats. The virus causes fever, diarrhea and decreased milk production in adult animals. In newborn animals, the virus can lead to arthrogryposis-hydranencephaly syndrome, which causes malformations of the limbs and heads. While there is currently no treatment for SBV infection, supportive treatment measures such as nutritional supplements can help address symptoms such as diarrhea and reduced milk production. Researchers are developing preventive drugs and vaccines to control the spread of the virus. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity for growth in the Schmallenberg virus treatment marke...
Read more